| •New Approved Drugs: | With all source categories (Figure 1) |
| •New Approved Drugs: | By source/year (Figure 2) |
| •Sources of all NCEs: | Where four or more drugs were approved per medical indication (Table 1), with listings of diseases with < 3 approved drugs |
| •Sources of Small-Molecule NCEs: | All subdivisions (Figure 3) |
| •Sources of Small-Molecule NCEs: | By source/year (Figure 4) |
| •Percent N/NB/ND: | By year (Figure 5) |
| •Total Small Molecules: | By year (Figure 6) |
| •Antibacterial Drugs: | Generic and trade names, year, reference and source (Table 2) |
| •Antifungal Drugs | Generic and trade names, year, reference and source (Table 3) |
| •Antiviral Drugs | Generic and trade names, year, reference and source (Table 4) |
| •Antiparasitic Drugs | Generic and trade names, year, reference and source (Table 5) |
| •Antiinfective Drugs | All molecules, source and numbers (Table 6) |
| •Antiinfective Drugs | Small molecules, source and numbers (Table 7) |
| •Anticancer Drugs | Generic and trade names, year, reference and source (Table 8; Figure 7) |
| •All Anticancer Drugs (very late 1930s-12/2010) | Generic and trade names, year, reference and source Table 9; Figures 8, 9) |
| •Antidiabetic Drugs | Generic and trade names, year, reference and source (Table 10) |